Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

Meet an Expert

Patients with severe COVID-19 pneumonia treated with leukotriene inhibitors are more likely to survive
5/24/22
Patients hospitalized with COVID-19 pneumonia had a 13.5% survival advantage when treated with a combination of leukotriene inhibitors (LTIs) and the steroid dexamethasone.
Media Advisory: Vaccine scientist Peter Hotez will give virtual talk sponsored by UB
5/20/22
UB is sponsoring a virtual talk on “The COVID-19 Vaccines: Science vs. Anti-science” by prominent vaccine scientist and “misinformation antagonist” Peter J. Hotez, MD, PhD, on June 9 at noon.
Study: Binge drinking has a powerful impact on the adolescent brain
5/14/22
UB preclinical study also demonstrates that low-to-moderate levels of drinking negatively affect the adolescent brain.
Study shows that more Black men have been dying from sleep apnea than white people and Black women
5/2/22
A UB study has found that over the past two decades, more Black men have been dying from obstructive sleep apnea than have white people or Black females.
Niagara Falls, Buffalo City Hall lighting to honor nurses
4/29/22
To honor nurses in Western New York and across the nation, the falls will be lit in blue and white.
UB receives $2.3 million to develop drugs that stop ovarian cancer from feeding on fat
4/27/22
UB has received a $2.3 million grant from the NIH to identify metabolic vulnerabilities of ovarian cancer and to develop potential treatments for the disease.
University at Buffalo-led team receives $10 million grant for advanced cyberinfrastructure research
4/22/22
The National Science Foundation-funded project includes Roswell Park and other partners; it will help ensure U.S. leadership in science and engineering, and help drive innovation in the U.S. economy.
Study tackles question that haunts people with MS: why do some develop severe disease while others never do?
4/21/22
A first-of-its-kind UB study is exploring the question that haunts MS patients as soon as they are diagnosed: Am I going to become severely disabled by my disease?
Treating chronic pelvic pain without drugs is focus of $3.3 million NIH award to UB expert on drug-free treatments
4/19/22
A UB expert on the behavioral treatment of chronic pain disorders has been awarded $3.3 million from the NIH to conduct a five-year clinical study of drug-free behavioral treatments for chronic pelvic pain in men and women.
UB and University of Zimbabwe HIV research training partnership receives $1.4 million from NIH
4/18/22
The initiative supports graduate students and postdoctoral fellows completing HIV research at the University of Zimbabwe.